Relay Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Cambridge, MA
RLAY chart
What traders are saying about $RLAY
Latest postsRelay Therapeutics, Inc. news
- Wall Street Analysts Are Bullish on Top Healthcare Picks
The Globe and Mail ·
- RLAY Stock Fundamentals & Key Ratios
Pluang ·
- Relay Therapeutics stock: Bank of America maintains a USD 25.00 target for Relay Therapeutics stock
ad-hoc-news.de ·
- Relay Therapeutics, Inc. Estimates – NASDAQ:RLAY
TradingView ·
- Rapport Therapeutics Insider Bought Shares Worth $974,278, According to a Recent SEC Filing
Yahoo Finance ·
- SINTX Technologies to release Q3 2026 earnings on Nov 5 with webcast and call
Pluang ·
- What Could Go Wrong With Recursion Pharmaceuticals Stock?
trefis.com ·
- Relay Therapeutics (RLAY) Stock Looks Fully Priced On Book Value
Yahoo Finance ·
- Is Relay Therapeutics (RLAY) Cheap After Its Pullback Or Is The Upside Priced In?
Yahoo Finance ·
- Raymond James Updates Healthcare Top Picks for October
Yahoo Finance ·
- Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
Yahoo Finance ·
- X-Chem Announces Phase 3 Milestone in Collaboration with Relay Therapeutics
Yahoo Finance ·
Relay Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $15.4M | $10.0M | $25.5M | $1.4M |
| Net income | -$276.5M | -$337.7M | -$342.0M | -$290.5M |
| Diluted EPS | $-1.61 | $-2.36 | $-2.79 | $-2.59 |
| Total assets (year end) | $621.3M | $871.3M | $844.0M | $1.10B |
| Cash and equivalents (year end) | $84.0M | $124.3M | $143.7M | $151.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Relay Therapeutics, Inc.
- Ticker
- RLAY (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1812364
Frequently asked questions
What exchange is Relay Therapeutics, Inc. listed on?
Relay Therapeutics, Inc. trades on the Nasdaq under the ticker symbol RLAY.
What industry is Relay Therapeutics, Inc. in?
Relay Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Relay Therapeutics, Inc. headquartered?
Relay Therapeutics, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Relay Therapeutics, Inc.'s fiscal year end?
Relay Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Relay Therapeutics, Inc. report?
Relay Therapeutics, Inc. reported $15.4M in revenue for calendar year 2025, according to its SEC filings.